NCT05669820View on ClinicalTrials.gov

Antisecretory Factor Glioblastoma Phase 2

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2026

Conditions
Glioblastoma
Interventions
DIETARY_SUPPLEMENT

Salovum

Salovum is an eggyolkpowder derived from hens fed with SPC (specially processed cereals) and contains increased amounts of the endogenous protein antisecretory factor.

DIETARY_SUPPLEMENT

Placebo egg yolk powder

Egg yolk powder derived from hen fed with normal feed.

Trial Locations (1)

22185

RECRUITING

Skåne University Hospital, Lund

All Listed Sponsors
collaborator

Lund University

OTHER

lead

Peter Siesjö

OTHER